DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Cytokinetics, Inc. (NASDAQ: CYTK)

7.09 -0.36 (-4.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTK $7.09 -4.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.38
Previous Close $7.45
Daily Range $7.00 - $7.44
52-Week Range $3.05 - $13.26
Market Cap $259.6M
P/E Ratio -20.14
Dividend (Yield) $0.00 (0.0%)
Volume 267,371
Average Daily Volume 704,095
Current FY EPS -$0.95

Sector

Healthcare

Industry

Drugs

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

News & Commentary Rss Feed

Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.

Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape

Cytokinetics (CYTK) Looks Good: Stock Soars 16.1% - Tale of the Tape

Cytokinetics (CYTK) Is Weak On High Volume Today

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Cl

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Cl

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update

Mid-Day Gainers From New Year's Eve 2014: NephroGenex And Other Biopharma Stocks

Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2

Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2%

Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target

Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More

See More CYTK News...

CYTK's Top Competitors

CYTK $7.09 (-4.83%)
Current stock: CYTK
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB